BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2017
View Archived Issues
Novartis and Allergan collaborate on phase IIb study in NASH
Read More
OncoMed reports endpoint not met in tarextumab study, discontinuation of brontictuzumab trial
Read More
ADDF investment supports progression of NDX-1017 towards phase I trials for Alzheimer's disease
Read More
argenx achieves preclinical milestone with ARGX-115 under AbbVie collaboration
Read More
BioSpecifics opens phase I study of Xiaflex for uterine fibroids
Read More
AAV8-whirlin restores balance and auditory function in preclinical model of Usher syndrome
Read More
Ionis and Ribo collaborate on RNA-targeted therapeutics in China
Read More
Interim results from a phase II trial of tetravalent dengue vaccine candidate
Read More
Regen identifies new series of compounds that activate NR2F6 nuclear receptor
Read More
Encouraging 24-week data reported from phase III study of burosumab in X-linked hypophosphatemia
Read More
Cardinal Health to acquire select businesses from Medtronic's PMR division
Read More
First report of a novel somatic mutation in PRKAR1A gene in Sertolli cell tumor
Read More
Nivalis Therapeutics and Alpine Immune Sciences to merge
Read More
Temple University, Cognition Therapeutics discover sigma-2 receptor ligands for Alzheimer's disease
Read More
Mateon reports interim data from FOCUS study of CA4P in platinum-resistant ovarian cancer
Read More
Cinclus Pharma enrolling participants in first-in-human trial of X-842
Read More
AstraZeneca targets Mcl-1 with AZD-5991 for hematological cancers
Read More
Argos updates status of ADAPT phase III trial of rocapuldencel-T in metastatic renal cell carcinoma
Read More
Ludwig Institute for Cancer Research identifies FEN1, ERCC5 and EXO1 nucleases inhibitors
Read More
Pfizer presents beta-secretase 1 inhibitors
Read More
The University of Florida discovers antimicrobial agents
Read More
ADX-102 granted U.S. orphan status for congenital ichthyosis
Read More
INCB-039110 receives FDA orphan designation for graft-versus-host disease
Read More
Vivace Therapeutics patents YAP1/TEAD interaction inhibitors
Read More
ADAMTSL3 found as a candidate biomarker in ischemic stroke
Read More
